Optimizing Outcomes in Myasthenia Gravis Through Personalized Care and Treatment Selection

home / peer-exchange / optimizing-outcomes-in-myasthenia-gravis-through-personalized-care-and-treatment-selection

A discussion between expert neurologists focuses on variability in presentation of myasthenia gravis (MG), guidance for diagnosis and personalization of care based on patient factors, and where targeted therapies can be utilized to control patient symptoms.

Presentation of Myasthenia Gravis (MG)

EP. 1: Presentation of Myasthenia Gravis (MG)

James F. Howard, MD;Nicholas J. Silvestri, MD, FAAN;Tuan Vu, MD;Ali Habib, MD;Beth Stein, MD

March 26th 2024

Expert neurologists discuss the presentation of myasthenia gravis (MG), focusing on the variability of symptoms from patient to patient.

Fatigue and Fluctuating Symptoms in MG

EP. 2: Fatigue and Fluctuating Symptoms in MG

James F. Howard, MD;Nicholas J. Silvestri, MD, FAAN;Tuan Vu, MD;Ali Habib, MD;Beth Stein, MD

March 26th 2024

Experts in neurology comment on fatigue and fluctuation of symptoms in MG and how that can contribute to a delay in diagnosis.

Accurate Diagnosis of MG

EP. 3: Accurate Diagnosis of MG

James F. Howard, MD;Nicholas J. Silvestri, MD, FAAN;Tuan Vu, MD;Ali Habib, MD;Beth Stein, MD

Beth Stein, MD, reviews critical steps towards diagnosing MG, taking a look at the different types of reliable testing for the disease.

Hospitalization of Older Patients in MG

EP. 4: Hospitalization of Older Patients in MG

James F. Howard, MD;Nicholas J. Silvestri, MD, FAAN;Tuan Vu, MD;Ali Habib, MD;Beth Stein, MD

Ali Habib, MD, comments on the prevalence of MG in older patients and the increasing rate of hospitalization and mortality within this group.

Treatment Approach in MG

EP. 5: Treatment Approach in MG

James F. Howard, MD;Nicholas J. Silvestri, MD, FAAN;Tuan Vu, MD;Ali Habib, MD;Beth Stein, MD

Expert neurologists discuss the factors that guide treatment selection in MG, shifting the framework to take patient preferences into account.

Quality of Life in MG

EP. 6: Quality of Life in MG

James F. Howard, MD;Nicholas J. Silvestri, MD, FAAN;Tuan Vu, MD;Ali Habib, MD;Beth Stein, MD

Experts in neurology highlight taking age and quality of life into consideration when approaching treatment of MG, as well as comment on the standard of care for patients.

Targeted Therapy Options in MG

EP. 7: Targeted Therapy Options in MG

James F. Howard, MD;Nicholas J. Silvestri, MD, FAAN;Tuan Vu, MD;Ali Habib, MD;Beth Stein, MD

April 16th 2024

Nicholas Silvestri, MD, FAAN, and Tuan Vu, MD, provide an overview of the current FDA-approved targeted therapies for the treatment of MG.

Use of Targeted Therapies in the Treatment Algorithm of MG

EP. 8: Use of Targeted Therapies in the Treatment Algorithm of MG

James F. Howard Jr., MD;Nicholas J. Silvestri, MD, FAAN;Tuan Vu, MD;Ali Habib, MD;Beth Stein, MD

April 16th 2024

Expert neurologists discuss the treatment algorithm of MG, focusing on the use of targeted therapies as well as barriers to their use.

Modes of Administration for Targeted Treatment in MG

EP. 9: Modes of Administration for Targeted Treatment in MG

James F. Howard Jr., MD;Nicholas J. Silvestri, MD, FAAN;Tuan Vu, MD;Ali Habib, MD;Beth Stein, MD

April 23rd 2024

Experts in neurology review the varied routes of administration of targeted treatment in MG, highlighting intravenous and subcutaneous formulations and how they can provide more patient-centric care.

Switching MG Treatment Due to Adverse Events or Poor Disease Control

EP. 10: Switching MG Treatment Due to Adverse Events or Poor Disease Control

James F. Howard Jr., MD;Nicholas J. Silvestri, MD, FAAN;Tuan Vu, MD;Ali Habib, MD;Beth Stein, MD

April 23rd 2024

Expert neurologists share approaches to switching MG treatment due to either poor disease control or adverse events.

Treatment Adherence in MG

EP. 11: Treatment Adherence in MG

James F. Howard, MD;Nicholas J. Silvestri, MD, FAAN;Tuan Vu, MD;Ali Habib, MD;Beth Stein, MD

April 30th 2024

Experts in neurology discuss how to ensure disease progression in not due to poor adherence to treatment in MG, emphasizing educating the patient about their disease.

Emerging Treatments in MG

EP. 12: Emerging Treatments in MG

James F. Howard, MD;Nicholas J. Silvestri, MD, FAAN;Tuan Vu, MD;Ali Habib, MD;Beth Stein, MD

April 30th 2024

Neurology experts provide an overview of emerging treatments in MG, highlighting biomarkers and new routes of administration.

Personalizing Care in MG

EP. 13: Personalizing Care in MG

James F. Howard, MD;Nicholas J. Silvestri, MD, FAAN;Tuan Vu, MD;Ali Habib, MD;Beth Stein, MD

Expert neurologists discuss patient-focused care when it comes to treating MG, also highlighting clinical trials.

The Pharmacist’s Role in MG Management

EP. 14: The Pharmacist’s Role in MG Management

James F. Howard, MD;Nicholas J. Silvestri, MD, FAAN;Tuan Vu, MD;Ali Habib, MD;Beth Stein, MD

Drs Howard, Silvestri, Vu, Habib, and Stein comment on the role of pharmacists in managing MG, emphasizing educating both the pharmacists and the patients.

Improving Patient Communication in MG

EP. 15: Improving Patient Communication in MG

James F. Howard, MD;Nicholas J. Silvestri, MD, FAAN;Tuan Vu, MD;Ali Habib, MD;Beth Stein, MD

Expert neurologists share thoughts on how to improve patient/physician communication and how listening to the patient needs will aid in managing MG.

Do Not Sell My Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.